news

Mini ETFs are always in the "ICU", and only the right medicine can cure both the symptoms and the root cause.

2024-08-12

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

Among the mini ETFs that have recently issued liquidation warnings, there are a number of products with very special changes in size: the fund size has been maintained below 50 million yuan all year round, but whenever the time for liquidation is approaching, it will be temporarily "injected" to above the 50 million yuan liquidation line, and then the fund size will decline again. The precise injection of funds every 40-50 working days allows these mini ETFs to be maintained for a long time.

Regarding this strange operation, the reporter interviewed several public fund institutions and learned that since the size of the mini ETF fund does not meet the standard, it may face liquidation. In order to maintain its listing status, the fund company may contact some sales institutions for help to expand the fund size through subscription, aiming to avoid fund liquidation. However, in the industry's view, such capital injection can only solve the urgent problem temporarily. To truly solve the dilemma of mini ETFs, the key lies in identifying the root cause of the obstruction of scale growth and taking appropriate measures to achieve both symptomatic and root cause treatment.

As for how to avoid and solve the dilemma of mini ETFs, there are currently three main solutions in the industry: expanding and strengthening, liquidating and exiting, and prudent layout. When designing products, fund companies have become more cautious, carefully considering the timing of layout, and reducing the generation of mini ETFs from the root of new product launches. (China Securities Journal)